Netflix stock slides as Paramount tops its Warner Bros bid, raising the stakes for NFLX

February 24, 2026
Netflix stock slides as Paramount tops its Warner Bros bid, raising the stakes for NFLX

New York, Feb 24, 2026, 11:51 EST — Regular session

  • Netflix shares slipped roughly 3% after a competing offer for Warner Bros. Discovery ratcheted up the takeover battle.
  • Paramount Skydance came back with an updated offer, ratcheting up the heat on Netflix—either raise their bid or step aside.
  • Eyes are on Warner Bros: investors await the next filing, the board’s move, and the March 20 vote.

Netflix stock slid 3.3% to $76.02 late Tuesday morning, with the recent turbulence continuing as investors weighed a new obstacle in the company’s pursuit of Warner Bros. Discovery.

Shares slipped after Warner Bros revealed it’s considering a sweetened Paramount Skydance bid, one that would beat Paramount’s earlier $30-a-share cash offer for the full company. That news keeps Netflix’s $27.75-per-share agreement on the table, but suddenly, Netflix may have to up its bid if it wants to clinch the deal. The current merger terms give Netflix four days to counter if Warner Bros calls the Paramount offer “superior,” according to Reuters. Reuters

Here’s what’s at stake: Warner Bros locked in March 20 for shareholders to vote on the Netflix deal, putting pressure on rivals to deliver—and justify—any counterbid fast. The clock is ticking, investor tolerance is running out.

Back in December, Netflix struck a deal to acquire Warner Bros’ studios and streaming arm—price tag: roughly $72 billion, according to Reuters. The move signals Netflix pushing for more scale and beefing up its content arsenal as streaming growth slows.

Netflix co-CEO Ted Sarandos played up the straightforward appeal of the company’s offer during a Feb. 20 interview, according to a transcript filed with the SEC on Monday. He called it “super-simple,” brushing off the surrounding commotion from competitors as little more than background chatter. Sarandos described Netflix as “super disciplined” and “willing to walk away and let someone else overpay.” He did not touch on whether Netflix might sweeten its bid. SEC

Some analysts say the market may be zeroing in on a price that shuts down the bidding for good. According to a Reuters report picked up by Investing.com, MoffettNathanson believes Paramount would probably settle things with an offer near $34 per share, putting an end to valuation debates and the fight itself.

Paramount is putting money on the table: it’s agreed to pay the $2.8 billion breakup fee Warner Bros would owe Netflix if the merger falls through. There’s also a so-called “ticking fee”—Paramount’s offer to add cash every quarter if finalizing the deal spills into next year. The Guardian

Politics is now in the mix. U.S. President Donald Trump called for Netflix to “immediately” remove board member Susan Rice, warning the company to “pay the consequences” if it didn’t comply. That threat added a fresh dose of uncertainty for investors eyeing a regulatory process that was already tricky. Variety

Deal structure is adding to the push and pull. Netflix wants Warner Bros to spin off its cable businesses as a standalone entity. Paramount? They’re after everything—networks included. That split shapes how the numbers stack up, both on price and funding, so traders are left running scenario after scenario.

The risk? Obvious enough. Should Netflix bump up its bid in a significant way, the stock could take a hit—investors tend to frown on overpaying, not to mention fresh integration headaches. But if Netflix keeps its wallet shut, it risks losing the target altogether and getting dragged through a gauntlet of questions about its game plan, with headlines likely to linger for months.

Warner Bros picked up 0.6% during that stretch. Paramount Skydance dropped roughly 1.3%. The market’s not showing much conviction on the outcome here; it’s still a game of probabilities.

Up next: eyes on whether Warner Bros gives Paramount’s bid the official nod as the superior offer, which would kick off Netflix’s four-day countdown. After that, the March 20 shareholder vote looms—potentially paving the way, or sending bidders back to the drawing board.

Technology News Today

  • UT Austin researchers develop compact CRISPR nuclease for in-body genome editing
    April 13, 2026, 3:55 PM EDT. UT Austin researchers, funded by the NIH and working with Metagenomi Therapeutics, have identified and engineered a compact CRISPR nuclease, Al3Cas12f, that fits into viral delivery systems. The team began from a naturally occurring Cas12f enzyme, 400-700 amino acids long, which could navigate the payload limits of AAV vectors used to deliver gene-editing instructions. Their engineered variant shows improved performance in human cells and outperforms two other Cas12f enzymes previously tested in mice. The work, described in Nature Structural & Molecular Biology, used cryo-electron microscopy and machine learning to reveal mechanistic features that explain efficiency differences, guiding rational design of even better, compact nucleases for potential therapeutic development.